On February 14, 2024, ADVI Health’s CEO and president, Marc Samuels, shared insight on GLP-1s with Scrip’s analysis: Scrip Asks….What Does 2024 Hold For Biopharma?

In his interview, Marc shared insights into the future of GLP-1s and what factors might enhance market opportunities in the coming years.

Read more on Marc’s insights.